← Open Payments lookup

NPI 1033245055: Open Payments

NPI 1033245055. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$320 in 17 payments from 7 companies in 2025. Trend: 2023 $303 · 2024 $430 · 2025 $320

Food & beverage: $320
CompanyPaymentsAmount
ABBVIE INC.4$65
E.R. Squibb & Sons, L.L.C.3$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$59
Collegium Pharmaceutical, Inc.2$42
Teva Pharmaceuticals USA, Inc.2$39
Otsuka America Pharmaceutical, Inc.2$36
Neurocrine BioSciences, Inc.1$15

Products named: VRAYLAR, COBENFY, CAPLYTA, Jornay PM, UZEDY, REXULTI, INGREZZA.